Prevention of cyclosporine-associated nephrotoxicity by K-MAP.
Teraoka
S
S
Department of Surgery, Tokyo Women's Medical College, Japan.
Sanaka
T
T
Sato
H
H
Fuchinoue
S
S
Honda
H
H
Kawai
T
T
Nakajima
I
I
Tojinbara
T
T
Fujita
S
S
Funakoshi
Y
Y
D010129:4-Aminobenzoic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D062365:Aminobenzoates / Q000627:therapeutic use*; D000818:Animals; D003524:Cyclosporins / Q000037:antagonists & inhibitors / Q000633:toxicity*; D011464:Epoprostenol / Q000096:biosynthesis; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D007677:Kidney Function Tests; D008297:Male; D008358:Mannose / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D013928:Thromboxane A2 / Q000096:biosynthesis; D014556:Urine / Q000032:analysis; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D003524:Cyclosporins; D062366:para-Aminobenzoates; D013928:Thromboxane A2; C055108:4-aminobenzoic acid-N-mannoside; D011464:Epoprostenol; D008358:Mannose; D010129:4-Aminobenzoic Acid